DNA methylation biomarker for prostate cancer shows promise for accurately determining a patient's risk

Analysis consistently shows elevated PITX2 methylation associated with the presence of a prostate tumor, reports a research team, suggesting an advance in determining a patient’s risk.

from Top Health News – ScienceDaily http://bit.ly/2hasViW
from Tumblr http://bit.ly/2h76YRJ